Evidence map›Paper›PMID 26833554›Full record

ArticleBritish journal of clinical pharmacology2016

Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia.

Elise Pape, Delphine Michel, Julien Scala-Bertola, Thomas Schiestel, Alexandre Harlé, Stéphane Bouchet, Audrey Contet, Cécile Pochon, Nicolas Gambier

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in British journal of clinical pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Elise PapeDepartment of Clinical Pharmacology and Toxicology, CHU Nancy, Nancy.
Delphine MichelDepartment of Paediatric Haematology/Oncology, CHU Nancy, Nancy.
Julien Scala-BertolaDepartment of Clinical Pharmacology and Toxicology, CHU Nancy, Nancy.
Thomas SchiestelDepartment of Clinical Pharmacology and Toxicology, CHU Nancy, Nancy.
Alexandre HarléFaculté de Pharmacie, Université de Lorraine, Nancy.
Stéphane BouchetDepartment of Clinical Pharmacology, CHU Bordeaux, France.
Audrey ContetDepartment of Paediatric Haematology/Oncology, CHU Nancy, Nancy.
Cécile PochonDepartment of Paediatric Haematology/Oncology, CHU Nancy, Nancy.
Nicolas GambierFaculté de Pharmacie, Université de Lorraine, Nancy.
Centre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Bordeaux · FRInstitut de Cancérologie de Lorraine · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26833554
PMCPMC4876178
OpenAlexW2296677966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.